Home

Blake Borgeson, Director: Recursion Pharmaceuticals RXRX Sell · Filed 24/09/19

Trade details

Type
Insider sale
Amount
$78,297.48
Shares · price
11,447 sh · $6.84 a share
Held after
7,109,875 sh
Trade date
24/09/17
Filed
24/09/19
Days to filing
2 days

Sold 0.2% of holdings

Share of holding sold
0.2%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/18~24/10/17

Blake Borgeson's recent trades

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $100.2K

    Filed 09/01

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $97.5K

    Filed 08/04

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $158.5K

    Filed 07/07

  • Blake Borgeson

    Sell10b5-1 planRecursion Pharmaceuticals

    $110.4K

    Filed 06/04

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $110.4K

    Filed 06/02